FDA Recall D-0388-2026

ANTHONY TRINH, 123Herbals LLC · Rosemead, CA

Class I — life-threatening Ongoing 206 days on record

Highest impact — Class I recall — FDA determination of strong likelihood of serious adverse health consequence or death. Distribution is nationwide and the recall remains in progress.

Product

SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China

Lot / code: All lots within expiry

Quantity: N/A

Reason for recall

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.

Recall record

Recall number: D-0388-2026
Classification: Class I
Status: Ongoing
Voluntary or mandated: Voluntary: Firm initiated
Firm notification: Press Release
Distribution: USA nationwide
Recall initiated: 2025-10-20
Classified by FDA Center: 2026-03-13
FDA published: 2026-03-11
Recalling firm: ANTHONY TRINH, 123Herbals LLC
Firm location: Rosemead, CA

Operational response

A Class I recall indicates a strong likelihood of serious adverse health consequence or death. Pull affected lots from active dispensing immediately. Segregate inventory in a marked, locked location pending destruction or return. If product has already been dispensed, identify affected patients and contact them by your standard recall-notification protocol.

For the official FDA enforcement record, see FDA's Recall Search.

‹ All recalls